javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited8.34901535592276.2837
Domestic EquitiesIPCA Laboratories Limited7.81451696381258.5963
Domestic EquitiesCipla Limited7.67761813462254.0660
Domestic EquitiesSai Life Sciences Limited6.86131957356227.0533
Domestic EquitiesGland Pharma Limited6.2599920673207.1514
Domestic EquitiesApollo Hospitals Enterprise Limited4.8124194767159.2512
Domestic EquitiesCohance Lifesciences Limited4.14643179881137.2119
Domestic EquitiesLaurus Labs Limited3.7626914169124.5098
Domestic EquitiesVijaya Diagnostic Centre Limited3.6992935530122.4141
Domestic EquitiesAlembic Pharmaceuticals Limited3.20881442516106.1836
Domestic EquitiesProcter & Gamble Health Limited2.915115928896.4648
Domestic EquitiesPfizer Limited2.788220064492.2661
Domestic EquitiesKovai Medical Center and Hospital Limited2.675316515688.5319
Domestic EquitiesIndoco Remedies Limited2.0564324568268.0490
Domestic EquitiesConcord Biotech Limited1.577849668852.2118
Domestic EquitiesEmcure Pharmaceuticals Limited1.506229389249.8441
Domestic EquitiesICICI Lombard General Insurance Company Limited1.307524141343.2660
Domestic EquitiesNephrocare Health Services Limited1.148863498338.0164
Domestic EquitiesAarti Drugs Limited0.979685215532.4160
Domestic EquitiesUnichem Laboratories Limited0.902785511129.8733
Domestic EquitiesAlkem Laboratories Limited0.62033733420.5262
Domestic EquitiesJupiter Life Line Hospitals Limited0.37749411712.4903
Domestic EquitiesLaxmi Dental Limited0.19702804016.5207
Total 75.6443 2503.1979
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments6.4680 214.0377
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.1251 -4.1389
Total 6.3429 209.8988
Overseas EquitiesIllumina Inc7.5343160400249.3235
Overseas EquitiesGlobus Medical Inc6.3440268800209.9350
Overseas EquitiesIntuitive Surgical Inc2.29721876876.0180
Overseas EquitiesAbbott Laboratories0.77973160025.8011
Overseas EquitiesGrail Inc0.180487335.9709
Total 17.1357 567.0485
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.87716125029.0260
Total 0.8771 29.0260
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.